Language Selector

Main Navigation

EMS at a glance

The EMS Group is active worldwide in the business areas High Performance Polymers and Specialty Chemicals. The companies within the group are consolidated in the EMS-CHEMIE HOLDING AG domiciled in Domat/Ems. The EMS-CHEMIE HOLDING AG is the only listed company (SIX Swiss Exchange, securities number 1.644.035).

Production site at Domat/Ems

Business Areas

The business area High Performance Polymers is comprised of EMS-GRIVORY and EMS-EFTEC. EMS-GRIVORY is leading specialised manufacturer of high-performance polyamides and the supplier with the widest range of polyamide materials. EMS-GRIVORY is made up of the three Business Units EMS-GRIVORY Europe, EMS-GRIVORY America and EMS-GRIVORY Asia. EMS-EFTEC is represented under the name EFTEC as leading supplier worldwide for adhesives, sealants and coatings including application engineering systems for the automotive industry.

The business area Specialty Chemicals is made up of the Business Units EMS-GRILTECH and EMS-PATVAG. EMS-GRILTECH is specialized in the development and production of fibres, fusible adhesives and adhesive yarn for technical and textile applications, adhesion promoters for the tyre industry, powder coatings and reactive diluents. EMS-PATVAG specialises in ignitors for airbag gas generators.

Company Strategy

EMS‘ company strategy is based on the following focus points:

  • EMS concentrates on operational growth with speciality products.
  • EMS defines Performance Polymers as core business.
  • EMS returns financial resources not required for operational business to the shareholders.

Locations / Employees

EMS has 26 production sites in 16 different countries and is represented throughout the world with company owned sales companies or by distributors/traders.

As of December 2013, the EMS Group has 2,670 employees worldwide with 132 apprentices based in Switzerland.

Key financial figures 2013

Net sales revenue (million CHF) 1,885
Net operating income/EBIT (million CHF) 369
EBIT margin 19.6%
Net financial income (million CHF) 16
Net income (million CHF) 324
Cash flow (million CHF) 379
Cash flow margin 20.1%
Balance sheet total (million CHF) 1,738
Balance sheet equity ratio 68.2%

Further Information

Communications
Dr Conrad Gericke
Phone +41 44 915 70 00

Investor Relations
Peter Germann
Phone +41 44 921 01 31

Board of Directors

The Board of Directors is made up of the following members:

Dr Ulf Berg, Chairman of the Board of Directors
Dr Ulf Berg, Chairman of the Board of Directors

Magdalena Martullo, Vice-President of the Board of Directors and Chief Executive Officer
Magdalena Martullo, Vice-President of the Board of Directors and Chief Executive Officer


Dr Joachim Streu
Dr Joachim Streu

Senior Management

Members of Senior Management:

Magdalena Martullo, Vice-President of the Board of Directors and Chief Executive Officer
Magdalena Martullo, Vice-President of the Board of Directors and Chief Executive Officer


Peter Germann, Chief Financial Officer (CFO)
Peter Germann, Chief Financial Officer (CFO)
Dr Rolf Holderegger
Dr Rolf Holderegger